organization · Reporting owner

MANCHESTER MANAGEMENT CO LLC

Disclosed activity across 7 companies

Tapewire entity: 71588
SEC CIK: 0001169253

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
BRAIN SCIENTIFIC INC.BRSF · Entity 124256	10% owner	June 15, 2022	August 04, 2022
Modular Medical, Inc.MODD · Entity 7488	Director · Chief Executive Officer · 10% owner · Director by Deputization	April 24, 2025	April 28, 2025
NEUROONE MEDICAL TECHNOLOGIES CorpNMTC · Entity 7808	10% owner	January 15, 2021	January 21, 2021
SANUWAVE Health, Inc.SNWV · Entity 7321	Director by Deputization	December 11, 2025	December 15, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

BRAIN SCIENTIFIC INC.

Report date June 15, 2022 · Filed August 04, 2022

Jointly reported with MANCHESTER MANAGEMENT PR, LLC, Manchester Explorer, L.P., JEB Partners, L.P., BESSER JAMES E, FRANK MORGAN C.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, $0.001 par valueSEC Table I · non-derivative	IndirectSee Footnote	19,545,187	Reported balance Holding disclosure · report date 2022-06-15 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 19,545,187 F1: The reported securities and warrants are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Common Stock, $0.001 par valueSEC Table I · non-derivative	IndirectSee Footnote	12,816,831	Reported balance Holding disclosure · report date 2022-06-15 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 12,816,831 F2: The reported securities and warrants are owned directly by JEB Partners, L.P. ("JEB Partners") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Common Stock, $0.001 par valueSEC Table I · non-derivative	Direct	8,028,706	Reported balance Holding disclosure · report date 2022-06-15 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 8,028,706 F3: The reported securities and warrants are directly owned by James E. Besser in his personal capacity.
Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.25	IndirectSee Footnote	Not disclosed	Reported balance Holding disclosure · report date 2022-06-15 · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · Balance Not disclosed F4: The reported warrants are exercisable as of the issue date, subject to certain conditions. F5: The reported warrants expire at 5:00pm E.D.T. on the fourth anniversary of the issue date, subject to certain conditions. F1: The reported securities and warrants are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.25	IndirectSee Footnote	Not disclosed	Reported balance Holding disclosure · report date 2022-06-15 · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · Balance Not disclosed F4: The reported warrants are exercisable as of the issue date, subject to certain conditions. F5: The reported warrants expire at 5:00pm E.D.T. on the fourth anniversary of the issue date, subject to certain conditions. F2: The reported securities and warrants are owned directly by JEB Partners, L.P. ("JEB Partners") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.25	Direct	Not disclosed	Reported balance Holding disclosure · report date 2022-06-15 · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · Balance Not disclosed F4: The reported warrants are exercisable as of the issue date, subject to certain conditions. F5: The reported warrants expire at 5:00pm E.D.T. on the fourth anniversary of the issue date, subject to certain conditions. F3: The reported securities and warrants are directly owned by James E. Besser in his personal capacity.
Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.35 · Expires 2031-10-01	Direct	Not disclosed	Reported balance Holding disclosure · report date 2022-06-15 · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · Balance Not disclosed F6: The reported warrants are subject to a blocker provision that prevents James E. Besser from exercising the warrants if he would be more than a 4.99% beneficial owner of the Common Stock, $0.001 par value, following such exercise. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to the Common Stock Purchase Warrant included as Exhibit 4.1 of the Issuer's 8-K filed on October 7, 2021, which is incorporated by reference. F3: The reported securities and warrants are directly owned by James E. Besser in his personal capacity.

Filing footnotes · ownership attribution and instrument terms

F1: The reported securities and warrants are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F2: The reported securities and warrants are owned directly by JEB Partners, L.P. ("JEB Partners") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F3: The reported securities and warrants are directly owned by James E. Besser in his personal capacity.

F4: The reported warrants are exercisable as of the issue date, subject to certain conditions.

F5: The reported warrants expire at 5:00pm E.D.T. on the fourth anniversary of the issue date, subject to certain conditions.

F6: The reported warrants are subject to a blocker provision that prevents James E. Besser from exercising the warrants if he would be more than a 4.99% beneficial owner of the Common Stock, $0.001 par value, following such exercise. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to the Common Stock Purchase Warrant included as Exhibit 4.1 of the Issuer's 8-K filed on October 7, 2021, which is incorporated by reference.

Modular Medical, Inc.

Report date April 24, 2025 · Filed April 28, 2025

Jointly reported with MANCHESTER MANAGEMENT PR, LLC, BESSER JAMES E, FRANK MORGAN C., Manchester Explorer, L.P., JEB Partners, L.P.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $0.94 · Expires 2035-04-24	Direct	125,000	Reported balance After 2025-04-24 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2025-04-24 · Grant · Acquired 125,000 · Balance 125,000 F1: The options were granted to the Reporting Person in accordance with the Issuer's Fiscal 2026 Two-Part FDA Submission and Product Milestone Bonus Program. The options will vest in two parts: (i) 50% if the Issuer submits a 510k related to MODDi to the FDA on or before October 31, 2025 and (ii) the remaining 50% if the manufacturing line is validated on MODDi with capacity to serve 6,000 patients by March 15, 2026. F2: The reported securities are directly owned by James E. Besser in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1.10 · Expires 2035-03-31	Direct	1,875	Reported balance Holding disclosure · report date 2025-04-24 · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · Balance 1,875 F3: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1.10 · Expires 2035-03-31	Direct	9,375	Reported balance Holding disclosure · report date 2025-04-24 · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · Balance 9,375 F3: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1.39 · Expires 2034-12-31	Direct	9,375	Reported balance Holding disclosure · report date 2025-04-24 · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · Balance 9,375 F3: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1.56 · Expires 2034-06-30	Direct	9,375	Reported balance Holding disclosure · report date 2025-04-24 · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · Balance 9,375 F3: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1.95 · Expires 2034-03-31	Direct	9,375	Reported balance Holding disclosure · report date 2025-04-24 · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · Balance 9,375 F3: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1.78 · Expires 2033-12-29	Direct	9,375	Reported balance Holding disclosure · report date 2025-04-24 · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · Balance 9,375 F3: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1.11 · Expires 2033-10-02	Direct	135,136	Reported balance Holding disclosure · report date 2025-04-24 · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · Balance 135,136 F8: This option has vested since (i) all verification and validation testing for the Registrant's initial pump product was completed by December 31, 2023 and (ii) the 510(K) premarket submission to the U.S. Food and Drug Administration ("FDA") for the Registrant's initial pump product was completed by January 31, 2024. F2: The reported securities are directly owned by James E. Besser in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1.16 · Expires 2033-09-30	Direct	9,375	Reported balance Holding disclosure · report date 2025-04-24 · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · Balance 9,375 F3: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $0.93 · Expires 2033-06-30	Direct	9,375	Reported balance Holding disclosure · report date 2025-04-24 · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · Balance 9,375 F3: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1.44 · Expires 2033-03-31	Direct	9,375	Reported balance Holding disclosure · report date 2025-04-24 · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · Balance 9,375 F3: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $2.14 · Expires 2032-12-31	Direct	1,875	Reported balance Holding disclosure · report date 2025-04-24 · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · Balance 1,875 F3: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $2.14 · Expires 2032-12-31	Direct	7,500	Reported balance Holding disclosure · report date 2025-04-24 · row 15 Instrument identity requires review; Table II rows are not merged. 1 source row Row 15 · Balance 7,500 F3: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $4.34 · Expires 2032-09-30	Direct	1,875	Reported balance Holding disclosure · report date 2025-04-24 · row 16 Instrument identity requires review; Table II rows are not merged. 1 source row Row 16 · Balance 1,875 F3: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $4.34 · Expires 2032-09-30	Direct	7,500	Reported balance Holding disclosure · report date 2025-04-24 · row 17 Instrument identity requires review; Table II rows are not merged. 1 source row Row 17 · Balance 7,500 F3: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $5.16 · Expires 2032-06-30	Direct	3,634	Reported balance Holding disclosure · report date 2025-04-24 · row 18 Instrument identity requires review; Table II rows are not merged. 1 source row Row 18 · Balance 3,634 F3: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $5.16 · Expires 2032-07-19	Direct	7,500	Reported balance Holding disclosure · report date 2025-04-24 · row 19 Instrument identity requires review; Table II rows are not merged. 1 source row Row 19 · Balance 7,500 F3: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $4.18 · Expires 2032-03-31	Direct	4,486	Reported balance Holding disclosure · report date 2025-04-24 · row 20 Instrument identity requires review; Table II rows are not merged. 1 source row Row 20 · Balance 4,486 F3: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $4.18 · Expires 2032-03-31	Direct	17,943	Reported balance Holding disclosure · report date 2025-04-24 · row 21 Instrument identity requires review; Table II rows are not merged. 1 source row Row 21 · Balance 17,943 F3: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $7.51 · Expires 2031-12-31	Direct	9,987	Reported balance Holding disclosure · report date 2025-04-24 · row 25 Instrument identity requires review; Table II rows are not merged. 1 source row Row 25 · Balance 9,987 F3: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $7.51 · Expires 2031-12-31	Direct	2,497	Reported balance Holding disclosure · report date 2025-04-24 · row 26 Instrument identity requires review; Table II rows are not merged. 1 source row Row 26 · Balance 2,497 F3: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $2.98 · Expires 2031-09-30	Direct	8,389	Reported balance Holding disclosure · report date 2025-04-24 · row 27 Instrument identity requires review; Table II rows are not merged. 1 source row Row 27 · Balance 8,389 F3: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F9: These Shares reflect a 3 for 1 reverse stock split effective November 26, 2021. F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $2.98 · Expires 2031-09-30	Direct	2,097	Reported balance Holding disclosure · report date 2025-04-24 · row 28 Instrument identity requires review; Table II rows are not merged. 1 source row Row 28 · Balance 2,097 F3: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F9: These Shares reflect a 3 for 1 reverse stock split effective November 26, 2021. F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $5.90 · Expires 2031-06-30	Direct	5,297	Reported balance Holding disclosure · report date 2025-04-24 · row 29 Instrument identity requires review; Table II rows are not merged. 1 source row Row 29 · Balance 5,297 F3: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F9: These Shares reflect a 3 for 1 reverse stock split effective November 26, 2021. F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $2.87 · Expires 2030-05-12	Direct	50,000	Reported balance Holding disclosure · report date 2025-04-24 · row 30 Instrument identity requires review; Table II rows are not merged. 1 source row Row 30 · Balance 50,000 F9: These Shares reflect a 3 for 1 reverse stock split effective November 26, 2021. F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.12 · Expires 2029-03-25	IndirectSee footnote	260,416	Reported balance Holding disclosure · report date 2025-04-24 · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · Balance 260,416 F5: Manchester Explorer, L.P. ("Explorer") acquired 260,416 units consisting of two shares of Common Stock, par value $0.001 per share and one warrant to purchase one share of Common Stock, par value $0.001 per share. It is anticipated that the warrants will become exercisable on or about March 25, 2025. F6: The reported securities are owned directly by Explorer and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR and (iv) Morgan C. Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $6.60 · Expires 2027-02-14	IndirectSee footnote	234,274	Reported balance Holding disclosure · report date 2025-04-24 · row 22 Instrument identity requires review; Table II rows are not merged. 1 source row Row 22 · Balance 234,274 F6: The reported securities are owned directly by Explorer and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR and (iv) Morgan C. Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $6.60 · Expires 2027-02-10	IndirectSee footnote	300,000	Reported balance Holding disclosure · report date 2025-04-24 · row 23 Instrument identity requires review; Table II rows are not merged. 1 source row Row 23 · Balance 300,000 F6: The reported securities are owned directly by Explorer and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR and (iv) Morgan C. Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $8.61 · Expires 2027-02-06	IndirectSee footnote	119,237	Reported balance Holding disclosure · report date 2025-04-24 · row 24 Instrument identity requires review; Table II rows are not merged. 1 source row Row 24 · Balance 119,237 F6: The reported securities are owned directly by Explorer and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR and (iv) Morgan C. Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.12 · Expires 2029-03-25	Direct	78,125	Reported balance Holding disclosure · report date 2025-04-24 · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · Balance 78,125 F7: James E. Besser acquired 78,125 units consisting of two shares of Common Stock, par value $0.001 per share and one warrant to purchase one share of Common Stock, par value $0.001 per share. It is anticipated that the warrants will become exercisable on or about March 25, 2025. F2: The reported securities are directly owned by James E. Besser in his personal capacity.

Filing footnotes · ownership attribution and instrument terms

F1: The options were granted to the Reporting Person in accordance with the Issuer's Fiscal 2026 Two-Part FDA Submission and Product Milestone Bonus Program. The options will vest in two parts: (i) 50% if the Issuer submits a 510k related to MODDi to the FDA on or before October 31, 2025 and (ii) the remaining 50% if the manufacturing line is validated on MODDi with capacity to serve 6,000 patients by March 15, 2026.

F2: The reported securities are directly owned by James E. Besser in his personal capacity.

F3: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.

F5: Manchester Explorer, L.P. ("Explorer") acquired 260,416 units consisting of two shares of Common Stock, par value $0.001 per share and one warrant to purchase one share of Common Stock, par value $0.001 per share. It is anticipated that the warrants will become exercisable on or about March 25, 2025.

F6: The reported securities are owned directly by Explorer and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR and (iv) Morgan C. Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F7: James E. Besser acquired 78,125 units consisting of two shares of Common Stock, par value $0.001 per share and one warrant to purchase one share of Common Stock, par value $0.001 per share. It is anticipated that the warrants will become exercisable on or about March 25, 2025.

F8: This option has vested since (i) all verification and validation testing for the Registrant's initial pump product was completed by December 31, 2023 and (ii) the 510(K) premarket submission to the U.S. Food and Drug Administration ("FDA") for the Registrant's initial pump product was completed by January 31, 2024.

F9: These Shares reflect a 3 for 1 reverse stock split effective November 26, 2021.

NEUROONE MEDICAL TECHNOLOGIES Corp

Report date January 15, 2021 · Filed January 21, 2021

Jointly reported with BESSER JAMES E, FRANK MORGAN C., MANCHESTER MANAGEMENT PR, LLC, Manchester Explorer, L.P.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	492,951	Reported balance Holding disclosure · report date 2021-01-15 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 492,951
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	4,750,000	Reported balance Holding disclosure · report date 2021-01-15 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 4,750,000 F1: The reported securities and warrants are directly owned by Manchester Explorer, L.P. JEB Partners, L.P and by Morgan C. Frank in his personal capacity. The reported securities and warrants are indirectly beneficially owned by Manchester Management PR, LLC and Manchester Management Company, LLC as a result of having investment discretion over Manchester Explorer, L.P. and JEB Partners, L.P. The reported securities and warrants may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and Manchester Management Company, LLC and by Morgan C. Frank, who serves as a portfolio manager and as a consultant for Manchester Management Company, LLC. F2: The Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.75 · Expires 2026-01-15	Direct	Not disclosed	Reported balance Holding disclosure · report date 2021-01-15 · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · Balance Not disclosed
WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.75 · Expires 2026-01-15	IndirectSee Footnotes	Not disclosed	Reported balance Holding disclosure · report date 2021-01-15 · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · Balance Not disclosed F1: The reported securities and warrants are directly owned by Manchester Explorer, L.P. JEB Partners, L.P and by Morgan C. Frank in his personal capacity. The reported securities and warrants are indirectly beneficially owned by Manchester Management PR, LLC and Manchester Management Company, LLC as a result of having investment discretion over Manchester Explorer, L.P. and JEB Partners, L.P. The reported securities and warrants may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and Manchester Management Company, LLC and by Morgan C. Frank, who serves as a portfolio manager and as a consultant for Manchester Management Company, LLC. F2: The Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: The reported securities and warrants are directly owned by Manchester Explorer, L.P. JEB Partners, L.P and by Morgan C. Frank in his personal capacity. The reported securities and warrants are indirectly beneficially owned by Manchester Management PR, LLC and Manchester Management Company, LLC as a result of having investment discretion over Manchester Explorer, L.P. and JEB Partners, L.P. The reported securities and warrants may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and Manchester Management Company, LLC and by Morgan C. Frank, who serves as a portfolio manager and as a consultant for Manchester Management Company, LLC.

F2: The Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SANUWAVE Health, Inc.

Report date December 11, 2025 · Filed December 15, 2025

Jointly reported with Manchester Explorer, L.P., FRANK MORGAN C., BESSER JAMES E, MANCHESTER MANAGEMENT PR, LLC

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, par value $0.001SEC Table I · non-derivative	IndirectSee Footnote	70,499	Reported balance After 2025-12-11 transaction · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · 2025-12-11 · Sale · Disposed 13,500 · Balance 70,499 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $31.05 to $31.525. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1: The reported securities are owned directly by JEB Partners, L.P. ("JEB Partners") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Manchester Explorer, L.P. ("Explorer"), (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Common Stock, par value $0.001SEC Table I · non-derivative	IndirectSee Footnote	63,999	Reported balance After 2025-12-12 transaction · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · 2025-12-12 · Sale · Disposed 6,500 · Balance 63,999 F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $30.765 to $31.60. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1: The reported securities are owned directly by JEB Partners, L.P. ("JEB Partners") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Manchester Explorer, L.P. ("Explorer"), (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Common Stock, par value $0.001SEC Table I · non-derivative	IndirectSee Footnote	863,980	Reported balance Holding disclosure · report date 2025-12-11 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 863,980 F5: The reported securities are owned directly by Explorer and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of Explorer, (ii) Manchester PR, the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Common Stock, par value $0.001SEC Table I · non-derivative	Direct	2,000	Reported balance Holding disclosure · report date 2025-12-11 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 2,000 F4: The reported securities are directly owned by James E. Besser in his personal capacity.
Common Stock, par value $0.001SEC Table I · non-derivative	Direct	52,653	Reported balance Holding disclosure · report date 2025-12-11 · row 5 Holding and transaction disclosures are not merged. 1 source row Row 5 · Balance 52,653 F6: The reported securities and warrants are directly owned by Morgan C. Frank in his personal capacity.

Filing footnotes · ownership attribution and instrument terms

F1: The reported securities are owned directly by JEB Partners, L.P. ("JEB Partners") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Manchester Explorer, L.P. ("Explorer"), (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $31.05 to $31.525. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $30.765 to $31.60. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The reported securities are directly owned by James E. Besser in his personal capacity.

F5: The reported securities are owned directly by Explorer and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of Explorer, (ii) Manchester PR, the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F6: The reported securities and warrants are directly owned by Morgan C. Frank in his personal capacity.

Past disclosures · reporting ended (3)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

FENNEC PHARMACEUTICALS INC.

Report date January 27, 2016 · Filed March 29, 2018

Jointly reported with MANCHESTER MANAGEMENT PR, LLC, Manchester Explorer, L.P., BESSER JAMES E, FRANK MORGAN C.

Section 16 reporting ended · disclosed 2018-03-29. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee footnote	1,666,666	Last balance in matching sequence After 2018-03-28 transaction · row 24 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 15 source rows Row 1 · 2018-03-08 · Sale · Disposed 10,000 · Balance 2,146,797 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 2 · 2018-03-12 · Sale · Disposed 18,560 · Balance 2,128,237 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 3 · 2018-03-13 · Sale · Disposed 16,934 · Balance 2,111,303 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 4 · 2018-03-14 · Sale · Disposed 13,600 · Balance 2,097,703 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 5 · 2018-03-16 · Sale · Disposed 6,423 · Balance 2,091,280 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 6 · 2018-03-16 · Sale · Disposed 2,120 · Balance 2,089,160 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 8 · 2018-03-19 · Sale · Disposed 200 · Balance 2,088,960 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 10 · 2018-03-20 · Sale · Disposed 4,200 · Balance 2,084,760 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 12 · 2018-03-20 · Sale · Disposed 15,183 · Balance 2,069,577 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 14 · 2018-03-21 · Sale · Disposed 210,311 · Balance 1,859,266 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 16 · 2018-03-22 · Sale · Disposed 20,000 · Balance 1,839,266 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 18 · 2018-03-23 · Sale · Disposed 3,500 · Balance 1,835,766 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 20 · 2018-03-27 · Sale · Disposed 22,707 · Balance 1,813,059 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 22 · 2018-03-28 · Sale · Disposed 605 · Balance 1,812,454 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 24 · 2018-03-28 · Sale · Disposed 145,788 · Balance 1,666,666 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Common StockSEC Table I · non-derivative	Direct	1,250,000	Last balance in matching sequence After 2018-03-28 transaction · row 25 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 10 source rows Row 7 · 2018-03-16 · Sale · Disposed 2,120 · Balance 1,672,494 F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Row 9 · 2018-03-19 · Sale · Disposed 200 · Balance 1,672,294 F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Row 11 · 2018-03-20 · Sale · Disposed 4,200 · Balance 1,668,094 F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Row 13 · 2018-03-20 · Sale · Disposed 15,183 · Balance 1,652,911 F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Row 15 · 2018-03-21 · Sale · Disposed 210,311 · Balance 1,442,600 F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Row 17 · 2018-03-22 · Sale · Disposed 20,000 · Balance 1,422,600 F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Row 19 · 2018-03-23 · Sale · Disposed 3,500 · Balance 1,419,100 F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Row 21 · 2018-03-27 · Sale · Disposed 22,707 · Balance 1,396,393 F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Row 23 · 2018-03-28 · Sale · Disposed 605 · Balance 1,395,788 F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Row 25 · 2018-03-28 · Sale · Disposed 145,788 · Balance 1,250,000 F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

Filing footnotes · ownership attribution and instrument terms

F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

FiEE, Inc.

Report date August 03, 2020 · Filed August 05, 2020

Jointly reported with Manchester Explorer, L.P., BESSER JAMES E, FRANK MORGAN C.

Section 16 reporting ended · disclosed 2020-08-05. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common Stock, $0.01 par valueSEC Table I · non-derivative	IndirectSee footnote	Reported balance After 2020-08-03 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2020-08-03 · Sale · Disposed 4,287,214 · Balance 0 F1: Manchester Management Company, LLC, a Delaware limited liability company ("Manchester"), is principally engaged in the business of providing investment management services. The reported securities are indirectly beneficially owned by Manchester as a result of it having investment discretion over certain advisory accounts it manages, including Manchester Explorer, L.P. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester, and by Morgan C. Frank, who serves as a portfolio manager and as a consultant for Manchester. Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Common Stock, $0.01 par valueSEC Table I · non-derivative	Direct	Reported balance After 2020-08-03 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2020-08-03 · Sale · Disposed 2,857,643 · Balance 0 F2: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.
Common Stock, $0.01 par valueSEC Table I · non-derivative	Direct	Reported balance After 2020-08-03 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 3 · 2020-08-03 · Sale · Disposed 143,357 · Balance 0 F3: The reported securities are directly owned by James E. Besser in his personal capacity.
Common Stock, $0.01 par valueSEC Table I · non-derivative	Direct	Reported balance After 2020-08-03 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 4 · 2020-08-03 · Sale · Disposed 142,857 · Balance 0 F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.

Filing footnotes · ownership attribution and instrument terms

F1: Manchester Management Company, LLC, a Delaware limited liability company ("Manchester"), is principally engaged in the business of providing investment management services. The reported securities are indirectly beneficially owned by Manchester as a result of it having investment discretion over certain advisory accounts it manages, including Manchester Explorer, L.P. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester, and by Morgan C. Frank, who serves as a portfolio manager and as a consultant for Manchester. Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F2: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

F3: The reported securities are directly owned by James E. Besser in his personal capacity.

F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.

SideChannel, Inc.

Report date September 30, 2019 · Filed October 03, 2019

Jointly reported with MANCHESTER MANAGEMENT PR, LLC, Manchester Explorer, L.P., BESSER JAMES E

Section 16 reporting ended · disclosed 2019-10-03. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common SharesSEC Table I · non-derivative	IndirectSee footnote	4,261,000	Reported balance After 2019-09-30 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2019-09-30 · Purchase · Acquired 10,600 · Balance 4,261,000 F1: The reported securities are directly owned by Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC and Manchester Management Company, LLC as a result of having investment discretion over certain advisory accounts they manage. Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange.

Filing footnotes · ownership attribution and instrument terms

F1: The reported securities are directly owned by Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC and Manchester Management Company, LLC as a result of having investment discretion over certain advisory accounts they manage. Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and Manchester Management Company, LLC.

F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
March 24, 2015 Filed Mar 29, 2018 20:47 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	5,000	$2.50	$12,500.00	Disclosure SEC source: 0000919574-18-002734 · p7852102_b.xml · nonDerivative · entry 22 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,403,694 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
March 24, 2015 Filed Mar 29, 2018 20:47 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	5,000	$2.50	$12,500.00	Disclosure SEC source: 0000919574-18-002734 · p7852102_b.xml · nonDerivative · entry 21 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,929,577 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
March 13, 2015 Filed Mar 29, 2018 20:47 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	18,000	$2.59	$46,620.00	Disclosure SEC source: 0000919574-18-002734 · p7852102_b.xml · nonDerivative · entry 20 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,398,694 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
March 13, 2015 Filed Mar 29, 2018 20:47 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	18,000	$2.59	$46,620.00	Disclosure SEC source: 0000919574-18-002734 · p7852102_b.xml · nonDerivative · entry 19 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,924,577 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
March 09, 2015 Filed Mar 29, 2018 20:47 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	1,000	$2.54	$2,540.00	Disclosure SEC source: 0000919574-18-002734 · p7852102_b.xml · nonDerivative · entry 18 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,380,694 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
March 09, 2015 Filed Mar 29, 2018 20:47 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	1,000	$2.54	$2,540.00	Disclosure SEC source: 0000919574-18-002734 · p7852102_b.xml · nonDerivative · entry 17 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,906,577 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
March 03, 2015 Filed Mar 29, 2018 20:47 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	500	$2.62	$1,310.00	Disclosure SEC source: 0000919574-18-002734 · p7852102_b.xml · nonDerivative · entry 16 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,379,694 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
March 03, 2015 Filed Mar 29, 2018 20:47 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	500	$2.62	$1,310.00	Disclosure SEC source: 0000919574-18-002734 · p7852102_b.xml · nonDerivative · entry 15 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,905,577 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
February 26, 2015 Filed Mar 29, 2018 20:47 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	100	$2.52	$252.00	Disclosure SEC source: 0000919574-18-002734 · p7852102_b.xml · nonDerivative · entry 14 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,379,194 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
February 26, 2015 Filed Mar 29, 2018 20:47 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	100	$2.52	$252.00	Disclosure SEC source: 0000919574-18-002734 · p7852102_b.xml · nonDerivative · entry 13 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,905,077 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
December 31, 2014 Filed Mar 29, 2018 20:47 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	8,500	$2.58	$21,930.00	Disclosure SEC source: 0000919574-18-002734 · p7852102_b.xml · nonDerivative · entry 12 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,379,094 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
December 31, 2014 Filed Mar 29, 2018 20:47 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	8,500	$2.58	$21,930.00	Disclosure SEC source: 0000919574-18-002734 · p7852102_b.xml · nonDerivative · entry 11 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,904,977 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
December 31, 2014 Filed Mar 29, 2018 20:47 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	22,600	$2.62	$59,212.00	Disclosure SEC source: 0000919574-18-002734 · p7852102_b.xml · nonDerivative · entry 10 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,370,594 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
December 31, 2014 Filed Mar 29, 2018 20:47 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	22,600	$2.62	$59,212.00	Disclosure SEC source: 0000919574-18-002734 · p7852102_b.xml · nonDerivative · entry 9 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,896,477 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
December 30, 2014 Filed Mar 29, 2018 20:47 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	10,000	$2.41	$24,100.00	Disclosure SEC source: 0000919574-18-002734 · p7852102_b.xml · nonDerivative · entry 8 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,347,994 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
December 30, 2014 Filed Mar 29, 2018 20:47 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	10,000	$2.41	$24,100.00	Disclosure SEC source: 0000919574-18-002734 · p7852102_b.xml · nonDerivative · entry 7 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,873,877 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
December 30, 2014 Filed Mar 29, 2018 20:47 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	6,400	$2.43	$15,552.00	Disclosure SEC source: 0000919574-18-002734 · p7852102_b.xml · nonDerivative · entry 6 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,337,994 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
December 30, 2014 Filed Mar 29, 2018 20:47 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	6,400	$2.43	$15,552.00	Disclosure SEC source: 0000919574-18-002734 · p7852102_b.xml · nonDerivative · entry 5 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,863,877 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
December 29, 2014 Filed Mar 29, 2018 20:47 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	600	$2.47	$1,482.00	Disclosure SEC source: 0000919574-18-002734 · p7852102_b.xml · nonDerivative · entry 4 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,331,594 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
December 29, 2014 Filed Mar 29, 2018 20:47 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	600	$2.47	$1,482.00	Disclosure SEC source: 0000919574-18-002734 · p7852102_b.xml · nonDerivative · entry 3 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,857,477 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
December 24, 2014 Filed Mar 29, 2018 20:47 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	6,200	$2.23	$13,826.00	Disclosure SEC source: 0000919574-18-002734 · p7852102_b.xml · nonDerivative · entry 2 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,330,994 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
December 24, 2014 Filed Mar 29, 2018 20:47 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	6,200	$2.23	$13,826.00	Disclosure SEC source: 0000919574-18-002734 · p7852102_b.xml · nonDerivative · entry 1 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,856,877 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
December 23, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	500	$2.23	$1,115.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 30 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,324,794 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
December 23, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	500	$2.23	$1,115.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 29 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,850,677 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: (Footnote 1 continued) Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
December 22, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	2,500	$2.23	$5,575.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 28 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,324,294 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
December 22, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	2,500	$2.23	$5,575.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 27 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,850,177 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: (Footnote 1 continued) Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
December 19, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	500	$2.53	$1,265.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 26 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,321,794 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
December 19, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	500	$2.53	$1,265.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 25 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,847,677 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: (Footnote 1 continued) Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
December 18, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	5,500	$2.34	$12,870.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 24 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,321,294 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
December 18, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	5,500	$2.34	$12,870.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 23 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,847,177 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: (Footnote 1 continued) Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
December 16, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	7,000	$2.40	$16,800.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 22 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,315,794 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
December 16, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	7,000	$2.40	$16,800.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 21 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,841,677 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: (Footnote 1 continued) Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
December 10, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	2,000	$2.50	$5,000.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 20 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,308,794 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
December 10, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	2,000	$2.50	$5,000.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 19 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,834,677 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: (Footnote 1 continued) Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
December 08, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	6,000	$2.68	$16,080.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 18 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,306,794 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
December 08, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	6,000	$2.68	$16,080.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 17 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,832,677 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: (Footnote 1 continued) Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
December 04, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	300	$2.76	$828.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 16 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300,794 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
December 04, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	300	$2.76	$828.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 15 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,826,677 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: (Footnote 1 continued) Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
December 03, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	10,000	$2.50	$25,000.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 14 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300,494 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
December 03, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	10,000	$2.50	$25,000.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 13 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,826,377 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: (Footnote 1 continued) Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
November 10, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	600	$2.72	$1,632.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 12 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,290,494 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
November 10, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	600	$2.72	$1,632.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 11 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,816,377 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: (Footnote 1 continued) Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
November 07, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	3,967	$2.56	$10,155.52	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 10 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,289,894 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
November 07, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	3,967	$2.56	$10,155.52	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 9 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,815,777 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: (Footnote 1 continued) Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
October 15, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	300	$2.69	$807.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 8 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,285,927 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
October 15, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	300	$2.69	$807.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 7 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,811,810 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: (Footnote 1 continued) Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
October 15, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	500	$2.68	$1,340.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 6 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,285,627 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
October 15, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	500	$2.68	$1,340.00	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 5 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,811,510 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: (Footnote 1 continued) Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
August 29, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	1,666	$2.46	$4,098.36	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 2 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,285,127 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document
August 29, 2014 Filed Mar 29, 2018 20:45 UTC	FENNEC PHARMACEUTICALS INC. FENC · Entity 5601	PurchaseCommon Stock	1,666	$2.46	$4,098.36	Disclosure SEC source: 0000919574-18-002732 · p7852102_a.xml · nonDerivative · entry 1 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,809,844 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management Company, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: (Footnote 1 continued) Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.